Volume 41 Issue 6
Jun.  2025
Turn off MathJax
Article Contents
Shang Xinzhi, Ding Mingxia, Lin Guo'an, et al. Analysis of the misdiagnosis causes and treatment strategies for burns combined with alcohol withdrawal syndrome[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2025, 41(6): 587-593. Doi: 10.3760/cma.j.cn501225-20240604-00211
Citation: Shang Xinzhi, Ding Mingxia, Lin Guo'an, et al. Analysis of the misdiagnosis causes and treatment strategies for burns combined with alcohol withdrawal syndrome[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2025, 41(6): 587-593. Doi: 10.3760/cma.j.cn501225-20240604-00211

Analysis of the misdiagnosis causes and treatment strategies for burns combined with alcohol withdrawal syndrome

doi: 10.3760/cma.j.cn501225-20240604-00211
Funds:

Military Medical Science and Technology Youth Cultivation Planning Program 20QNPY074

More Information
  • Corresponding author: Xiao Rong, Email: xr131@hotmail.com
  • Received Date: 2024-06-04
  •   Objective  To investigate the misdiagnosis causes and treatment strategies for burns combined with alcohol withdrawal syndrome (AWS).  Methods  This study was a retrospective observational study. From January 2014 to December 2023, 334 male burn patients aged 29-90 (53±11) years and combined with alcohol dependence were admitted to the PLA Burn Center of the 990th Hospital of Joint Logistics Support Force. Patients were divided into AWS group (29 cases) and non-AWS group (305 cases) based on whether AWS developed or not. The misdiagnosis causes and treatment outcomes of AWS of patients in AWS group were analyzed. The total burn surface area, full-thickness burn area, burn index, hospitalization day, and mortality were compared between patients in the two groups. The 334 patients were further stratified by burn severity into mild-moderate burn patients (306 cases), severe burn patients (11 cases), and critically severe burn patients (17 cases), and the correlation between AWS incidence and burn severity in patients with burns combined with alcohol dependence was analyzed.  Results  The misdiagnosis causes of AWS in AWS group of patients were primarily insufficient clinician awareness of AWS (48.3%, 14/29) and then overlapping symptoms between AWS and burn-related complications, such as shock, electrolyte imbalance, stress-induced mental disorders, and epilepsy (51.7%, 15/29), which influenced judgement of the clinicians. After active treatment, the AWS symptoms alleviated obviously or disappeared in 27 patients, while 2 patients died of multiple organ failure. Compared with those in non-AWS group, the total burn surface area, full-thickness burn area, burn index, and hospitalization day of patients in AWS group were significantly increased (with Z values of -8.35, -6.98, -8.32, and -4.56, respectively, P < 0.05). The mortality of patients in AWS group was 6.9% (2/29), which was significantly higher than 0.7% (2/305) in non-AWS group (P < 0.05). The AWS incidences of patients with mild-moderate burn, severe burn, and critically severe burn were 4/306, 8/11, and 17/17, respectively, and the AWS incidences of burn patients combined with alcohol dependence had strongly positive correlation with burn severity (r=0.87, P < 0.05).  Conclusions  The AWS incidence in burn patients is low, and its incidence is closely correlated with burn severity, predominantly affecting males over 40 years old with prolonged alcohol use and severe burns. The AWS symptoms appear later and are easily masked by symptoms of burn complications, making it easy to misdiagnose or even miss the diagnosis. Therefore, clinicians should strengthen the screening of alcohol drinking history in male severe burn patients over 40 years old, and consult with physicians of relevant disciplines in a timely manner to ensure early diagnosis and intervention to reduce the risks of misdiagnosis or missed diagnosis and to improve prognosis.

     

  • (1) It was revealed that the severity of burns had a significantly positive correlation with the incidence of alcohol withdrawal syndrome (AWS), and patients with severe burns combined with alcohol dependence had an extremely high risk of developing AWS, which should be given high attention by clinicians.
    (2) It was proposed that clinicians should improve their understanding of AWS after burns, and emphasized inquiry of patients' medical history, especially the screening of alcohol drinking history of male patients over 40 years old with severe burns, which was an crucial measure to prevent misdiagnosis and missed diagnosis of AWS. Besides, multidisciplinary team collaboration was an essential strategy for accurate diagnosis of AWS.
  • loading
  • [1]
    Bayard M, McIntyre J, Hill KR, et al. Alcohol withdrawal syndrome[J]. Am Fam Physician, 2004, 69(6): 1443-1450.
    [2]
    Gottlieb M, Chien N, Long B. Managing alcohol withdrawal syndrome[J]. Ann Emerg Med, 2024, 84(1): 29-39. DOI: 10.1016/j.annemergmed.2024.02.016.
    [3]
    Shirk L, Reinert JP. The role of propofol in alcohol withdrawal syndrome: a systematic review[J]. J Clin Pharmacol, 2025, 65(2): 170-178. DOI: 10.1002/jcph.6135.
    [4]
    Dervaux A, Laqueille X. Alcohol use disorders[J]. Lancet, 2016, 387(10035): 2292. DOI: 10.1016/S0140-6736(16)30689-4.
    [5]
    Chassin L, Sher KJ. Understanding alcohol use and alcohol use disorders from a developmental psychopathology perspective: research advances, challenges, and future directions[J]. Dev Psychopathol, 2024, 36(5): 2604-2618. DOI: 10.1017/S0954579424000671.
    [6]
    Khatore P, Yolanda H, Joyner J, et al. Digital interventions for alcohol use and alcohol use disorders in low-and-middle-income countries: a systematic review[J]. Oxf Open Digit Health, 2025, 3: oqaf004. DOI: 10.1093/oodh/oqaf004.
    [7]
    Hoonpongsimanont W, Ghanem G, Sahota P, et al. Association of blood alcohol and alcohol use disorders with emergency department disposition of trauma patients[J]. West J Emerg Med, 2022, 23(2): 158-165. DOI: 10.5811/westjem.2021.9.51376.
    [8]
    吴庆云, 任秋芝, 张志华, 等. 烧伤合并酒精依赖戒断综合征12例[J]. 中华烧伤杂志, 2005, 21(2): 113. DOI: 10.3760/cma.j.issn.1009-2587.2005.02.025.
    [9]
    Al-Maqbali JS, Al-Maqrashi N, Al-Huraizi A, et al. Clinical characteristics and health outcomes in patients with alcohol withdrawal syndrome: an observational study from Oman[J]. Ann Saudi Med, 2022, 42(1): 52-57. DOI: 10.5144/0256-4947.2022.52.
    [10]
    Day E, Daly C. Clinical management of the alcohol withdrawal syndrome[J]. Addiction, 2022, 117(3): 804-814. DOI: 10.1111/add.15647.
    [11]
    International Advisory Group for the Revision of ICD-10 Mental and Behavioural Disorders. A conceptual framework for the revision of the ICD-10 classification of mental and behavioural disorders[J]. World Psychiatry, 2011, 10(2): 86-92. DOI: 10.1002/j.2051-5545.2011.tb00022.x.
    [12]
    中华医学会精神科分会. 中国精神障碍分类与诊断标准[M]. 3版. 济南: 山东科学技术出版社, 2001.
    [13]
    Bain AP, Garcia I, Leveno M, et al. Early extracorporeal membranous oxygenation and burn excision in severe burn and inhalation injury[J]. Scars Burn Heal, 2024, 10: 20595131241302942. DOI: 10.1177/20595131241302942.
    [14]
    王吉耀, 葛均波, 邹和建. 实用内科学[M]. 16版. 北京: 人民卫生出版社, 2022.
    [15]
    Zhang Z, Li X, Yang M. Wernicke's encephalopathy with MRI findings despite coadministration of thiamine and glucose[J]. Cureus, 2024, 16(7): e64192. DOI: 10.7759/cureus.64192.
    [16]
    陈大夫, 钟宇, 王德怀, 等. 烧伤患者的流行病学分析[J]. 中华烧伤杂志, 2004, 20(4): 240-241. DOI: 10.3760/cma.j.issn.1009-2587.2004.04.018.
    [17]
    Abarca L, Guilabert P, Martin N, et al. Epidemiology and mortality in patients hospitalized for burns in Catalonia, Spain[J]. Sci Rep, 2023, 13(1): 14364. DOI: 10.1038/s41598-023-40198-2.
    [18]
    Glann JK, Carman M, Thompson J, et al. Alcohol withdrawal syndrome: improving recognition and treatment in the emergency department[J]. Adv Emerg Nurs J, 2019, 41(1): 65-75. DOI: 10.1097/TME.0000000000000226.
    [19]
    Unlu H, Macaron MM, Ayraler Taner H, et al. Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies[J]. Front Psychiatry, 2023, 14: 1266424. DOI: 10.3389/fpsyt.2023.1266424.
    [20]
    Balian J, Cho NY, Vadlakonda A, et al. A national analysis of alcohol withdrawal syndrome in patients with operative trauma[J]. Surg Open Sci, 2024, 19: 199-204. DOI: 10.1016/j.sopen.2024.05.001.
    [21]
    Van Yperen DT, Van Lieshout EMM, Verhofstad MHJ, et al. Epidemiology of burn patients admitted in the Netherlands: a nationwide registry study investigating incidence rates and hospital admission from 2014 to 2018[J]. Eur J Trauma Emerg Surg, 2022, 48(3): 2029-2038. DOI: 10.1007/s00068-021-01777-y.
    [22]
    徐艳, 谭维维, 樊萍, 等. 5-HTT基因多态性与酒精使用障碍的关联性研究[J]. 中华行为医学与脑科学杂志, 2017, 26(10): 907-912. DOI: 10.3760/cma.j.issn.1674-6554.2017.10.009.
    [23]
    Di Nicola M, Pepe M, Panaccione I, et al. Update on pharmacological treatment for comorbid major depressive and alcohol use disorders: the role of extended-release trazodone[J]. Curr Neuropharmacol, 2023, 21(11): 2195-2205. DOI: 10.2174/1570159X21666230403080624.
    [24]
    Cao J, LaRocque E, Li D. Associations of the 5-hydroxytryptamine (serotonin) receptor 1B gene (HTR1B) with alcohol, cocaine, and heroin abuse[J]. Am J Med Genet B Neuropsychiatr Genet, 2013, 162B(2): 169-176. DOI: 10.1002/ajmg.b.32128.
    [25]
    Oo KZ, Aung YK, Jenkins MA, et al. Associations of 5HTTLPR polymorphism with major depressive disorder and alcohol dependence: a systematic review and meta-analysis[J]. Aust N Z J Psychiatry, 2016, 50(9): 842-857. DOI: 10.1177/0004867416637920.
    [26]
    Brookwell L, Hogan C, Healy D, et al. Ninety-three cases of alcohol dependence following SSRI treatment[J]. Int J Risk Saf Med, 2014, 26(2): 99-107. DOI: 10.3233/JRS-140616.
    [27]
    You Z, Jain S, Shen S, et al. Pathophysiology and management of burn injury-induced pain[J]. Burns Open, 2025, 10: 100396. DOI: 10.1016/j.burnso.2025.100396.
    [28]
    杨雪, 盛利霞, 郝伟, 等. 酒精戒断综合征: 机制、评估及药物治疗进展[J]. 中国药物滥用防治杂志, 2014, 20(3): 181-186. DOI: 10.3969/j.issn.1006-902X.2014.03.027.
    [29]
    Sedghiani I, Mokline A, Fredj H, et al. Hypernatremia risk factors and prognostic impact in burn patients: a case control study[J]. Ann Burns Fire Disasters, 2021, 34(2): 135-139.
    [30]
    Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens)[J]. N Engl J Med, 2014, 371(22): 2109-2113. DOI: 10.1056/NEJMra1407298.
    [31]
    Saitz R. Clinical practice. Unhealthy alcohol use[J]. N Engl J Med, 2005, 352(6): 596-607. DOI: 10.1056/NEJMcp042262.
    [32]
    Costa IN, Reis JS, Monteiro AO, et al. Alcohol withdrawal syndrome as a precipitating factor of takotsubo cardiomyopathy on a background of Wernicke's encephalopathy[J]. Cureus, 2022, 14(7): e27288. DOI: 10.7759/cureus.27288.
    [33]
    Ungur AL, Neumann T, Borchers F, et al. Perioperative management of alcohol withdrawal syndrome[J]. Visc Med, 2020, 36(3): 160-166. DOI: 10.1159/000507595.
    [34]
    Alzghoul H, Al-Said MI, Obeidat O, et al. Effectiveness of gabapentin as a benzodiazepine-sparing agent in alcohol withdrawal syndrome[J]. Medicina (Kaunas), 2024, 60(6): 1004. DOI: 10.3390/medicina60061004.
    [35]
    Fiore M, Alfieri A, Torretta G, et al. Dexmedetomidine as adjunctive therapy for the treatment of alcohol withdrawal syndrome: a systematic review and meta-analysis[J]. Pharmaceuticals (Basel), 2024, 17(9): 1125. DOI: 10.3390/ph17091125.
    [36]
    Steel TL, Malte CA, Bradley KA, et al. Benzodiazepine treatment and hospital course of medical inpatients with alcohol withdrawal syndrome in the veterans health administration[J]. Mayo Clin Proc Innov Qual Outcomes, 2022, 6(2): 126-136. DOI: 10.1016/j.mayocpiqo.2021.11.010.
    [37]
    Shah P, Stegner-Smith KL, Rachid M, et al. Front-loaded versus low-intermittent phenobarbital dosing for benzodiazepine-resistant severe alcohol withdrawal syndrome[J]. J Med Toxicol, 2022, 18(3): 198-204. DOI: 10.1007/s13181-022-00900-8.
    [38]
    Ho TT, Noble M, Tran BA, et al. Clinical impact of the CYP2C19 gene on diazepam for the management of alcohol withdrawal syndrome[J]. J Pers Med, 2023, 13(2): 285. DOI: 10.3390/jpm13020285.
    [39]
    Beg M, Fisher S, Siu D, et al. Treatment of alcohol withdrawal syndrome with and without dexmedetomidine[J]. Perm J, 2016, 20(2): 49-53. DOI: 10.7812/TPP/15-113.
    [40]
    Yavarovich ER, Bintvihok M, McCarty JC, et al. Association between dexmedetomidine use for the treatment of alcohol withdrawal syndrome and intensive care unit length of stay[J]. J Intensive Care, 2019, 7: 49. DOI: 10.1186/s40560-019-0405-1.
    [41]
    Fiore M, Torretta G, Passavanti MB, et al. Dexmedetomidine as adjunctive therapy for the treatment of alcohol withdrawal syndrome: a systematic review protocol[J]. JBI Database System Rev Implement Rep, 2019, 17(10): 2159-2164. DOI: 10.11124/JBISRIR-2017-003949.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Article Metrics

    Article views (137) PDF downloads(14) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return